Impact of sex and age on the performance of FINDRISC: The HUNT study in Norway

BMJ Open Diabetes Research and Care

Volumn 4, Issue 1, 2016, Pages

  Jølle, Anne ^a   Midthjell, Kristian ^a   Holmen, Jostein ^a   Tuomilehto, Jaakko ^b,c,d,e,f   Carlsen, Sven M ^a,g   Shaw, Jonathan ^h   Åsvold, Bjørn O ^a,g  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b DASMAN DIABETES INSTITUTE   (Kuwait)

^c DANUBE UNIVERSITY KREMS   (Austria)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^g TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^h BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C; HEXOKINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; DIABETIC PATIENT; FEMALE; FINNISH DIABETES RISK SCORE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART RATE; HIGH RISK POPULATION; HUMAN; MALE; MIDDLE AGED; ORAL GLUCOSE TOLERANCE TEST; OSCILLOMETRY; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEX; VERY ELDERLY;

EID: 85006190194     PISSN: None     EISSN: 20524897     Source Type: Journal    
DOI: 10.1136/bmjdrc-2016-000217     Document Type: Article

References (34)

1. Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-49.
2. Menke A, Casagrande S, Geiss L, et al. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA 2015;314:1021-9.
3. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50.
4. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
5. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.
6. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26:725-31.
7. Paulweber B, Valensi P, Lindstrom J, et al. A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res 2010;42(Suppl 1):S3-36.
8. Saaristo T, Peltonen M, Lindström J, et al. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. Diab Vasc Dis Res 2005;2:67-72.
9. Makrilakis K, Grammatikou S, Liatis S, et al. The effect of a non-intensive community-based lifestyle intervention on the prevalence of metabolic syndrome. The DEPLAN study in Greece. Hormones (Athens, Greece) 2012;11:316-24.
10. Franciosi M, De Berardis G, Rossi MC, et al. Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study. Diabetes Care 2005;28:1187-94.
11. Winkler G, Hidvegi T, Vandorfi G, et al. Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire. Med Sci Monit 2013;19:67-72.
12. Garcia-Alcala H, Genestier-Tamborero CN, Hirales-Tamez O, et al. Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico. Diabetes Metab Syndr Obes 2012;5:403-6.
13. Barengo NC, Acosta T, Arrieta A, et al. Screening for people with glucose metabolism disorders within the framework of the DEMOJUAN project (DEMOnstration area for primary prevention of type 2 diabetes, JUAN Mina and Barranquilla, Colombia). Diabetes Metab Res Rev 2013. Epub ahead of print Sept. 2nd 2013. doi: 10.1002/dmrr.2462
14. Ku GM, Kegels G. The performance of the Finnish Diabetes Risk Score, a modified Finnish Diabetes Risk Score and a simplified Finnish Diabetes Risk Score in community-based cross-sectional screening of undiagnosed type 2 diabetes in the Philippines. Prim Care Diabetes 2013;7:249-59.
15. Soriguer F, Valdes S, Tapia MJ, et al. [Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study]. Med Clin (Barc) 2012;138:371-6.
16. Hellgren MI, Petzold M, Bjorkelund C, et al. Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in Swedish primary care. A cross-sectional population-based study. Diabet Med 2012;29:1501-5.
17. Zhang L, Zhang Z, Zhang Y, et al. Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999-2010. PLoS ONE 2014;9:e97865.
18. Tankova T, Chakarova N, Atanassova I, et al. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Res Clin Pract 2011;92:46-52.
19. Saaristo T, Moilanen L, Jokelainen J, et al. Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D). Prim Care Diabetes 2010;4:231-9.
20. Krokstad S, Langhammer A, Hveem K, et al. Cohort profile: the HUNT study, Norway. Int J Epidemiol 2013;42: 968-77.
21. Schwarz PE, Lindstrom J, Kissimova-Scarbeck K, et al. The European perspective of type 2 diabetes prevention: diabetes in Europe-prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 2008;116:167-72.
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
23. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the diagnosis of diabetes mellitus Abbreviated Report of a WHO Consultation, 2011.
24. Statistics Norway. 2015. http://www.ssb.no
25. Langhammer A, Krokstad S, Romundstad P, et al. The HUNT study: participation is associated with survival and depends on socioeconomic status, diseases and symptoms. BMC Med Res Methodol 2012;12:143.
26. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011;378:31-40.
27. Wandell PE, Carlsson AC. Gender differences and time trends in incidence and prevalence of type 2 diabetes in Sweden-a model explaining the diabetes epidemic worldwide today? Diabetes Res Clin Pract 2014;106:e90-2.
28. Chen L, Magliano DJ, Balkau B, et al. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 2010;192:197-202.
29. Fuentes A, Desrocher M. The effects of gender on the retrieval of episodic and semantic components of autobiographical memory. Memory 2013;21:619-32.
30. GPs and emergency primary health care, 2014. Oslo: Statistics Norway, 2015 [Cited June 14, 2016]. https://www.ssb.no/en/helse/ statistikker/fastlegetj/aar/2015-06-12
31. Nossen JP. Hva foregår på legekontorene? Konsultasjonsstatistikk for 2006. (What happens at the GP' surgeries? Consultation statistics for 2006.) Report No.:4/2007. Oslo: The Norwegian Labour and Welfare Administration; 2007. Norwegian.
32. Ford ES, Maynard LM, Li C. Trends in mean waist circumference and abdominal obesity among US adults, 1999-2012. JAMA 2014;312:1151-3.
33. Janssen I, Shields M, Craig CL, et al. Prevalence and secular changes in abdominal obesity in Canadian adolescents and adults, 1981 to 2007-2009. Obes Rev 2011;12:397-405.
34. Midthjell K, Lee CM, Langhammer A, et al. Trends in overweight and obesity over 22 years in a large adult population: the HUNT Study, Norway. Clin Obes 2013;3:12-20.